Your browser doesn't support javascript.
loading
Clinical Relevance of Autoantibodies and Inflammatory Parameters in Non-infectious Scleritis.
Vergouwen, D P C; Ten Berge, J C; Boukhrissi, S; Rothova, A; Schreurs, M W J.
Afiliação
  • Vergouwen DPC; Department of Ophthalmology, Erasmus MC, University Medical Center, Rotterdam, The Netherlands.
  • Ten Berge JC; Department of Immunology, Erasmus MC, University Medical Center, Rotterdam, The Netherlands.
  • Boukhrissi S; Department of Ophthalmology, Erasmus MC, University Medical Center, Rotterdam, The Netherlands.
  • Rothova A; Department of Immunology, Erasmus MC, University Medical Center, Rotterdam, The Netherlands.
  • Schreurs MWJ; Department of Ophthalmology, Erasmus MC, University Medical Center, Rotterdam, The Netherlands.
Ocul Immunol Inflamm ; 30(7-8): 1859-1865, 2022.
Article em En | MEDLINE | ID: mdl-34464233
ABSTRACT

PURPOSE:

Scleritis is a potentially blinding disorder, with highly unpredictable course and outcome. We analyzed the prevalence and clinical relevance of autoantibodies and inflammatory parameters in non-infectious scleritis.

METHODS:

Retrospective analysis of laboratory findings in all consecutive patients at the department of Ophthalmology of the Erasmus MC with non-infectious scleritis.

RESULTS:

We included 81 patients with non-infectious scleritis. A systemic autoimmune disease was present in 46%. Positive anti-nuclear antibodies were found in 30%, anti-neutrophil cytoplasmic antibodies were positive in 19%, and the presence of rheumatoid factor was shown in 17%. The aforementioned autoantibodies, as well as inflammatory parameters, failed to show prognostic clinical value. In contrast, anti-citrullinated peptide antibodies (ACPA), found in 9% of scleritis patients, were significantly associated with the development of scleral necrosis (P = .01).

CONCLUSIONS:

The presence of ACPA in patients with non-infectious scleritis was associated with the development of scleral necrosis.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Autoanticorpos / Relevância Clínica Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Autoanticorpos / Relevância Clínica Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article